Children's Hospital and Regional Medical Center
Extracorporeal Life Support Program |
| Author |
Created
03/27/98 |
Reviewed
12/29/05 |
Revised
1/22/08 |
|
- Surgical Director:
- David Michael McMullan, M.D.
- office:206-987-2762
- page:206-987-2131
- Nurse Coordinator:
- Karen Kelly, R.N.
- office:206-987-1470
- page:206-469-6778
Children's Hospital and Regional Medical Center in Seattle provides extracorporeal life
support (ECLS) for neonates and children in the Washington-Alaska-Montana-Idaho region.
This information will acquaint you with ECLS referral criteria so that you can use the
service to your best advantage.
[Jump to Table of Contents]
Table of Contents
What is ECLS?
What are ECLS use criteria in Neonates?
What are ECLS use criteria for Pediatric Respiratory Failure?
What are ECLS use criteria in Pediatric Cardiac Failure?
How do I predict mortality?
Which patients are NOT candidates for ECLS?
If I suspect a patient may be a candidate for ECLS, when should I
involve the ECLS Team?
How can I reach the ECLS Team?
International Summary of ECLS Statistics from the
Extracorporeal Life Support Organization
Extracorporeal Life Support Organization Statistics
-Neonatal Cases Only
Extracorporeal Life Support Organization Statistics
-Pediatric Respiratory Cases Only
Extracorporeal Life Support Organization Statistics
-Cardiac Cases Only
ELSO Homepage (Extracorporeal Life Support
Organization, Ann Arbor, MI)
Extracorporeal Life Support Bulletin Board
Other ECLS Web Sites on the INTERNET
What is ECLS?
ECLS is a form of cardiopulmonary bypass that provides support for patients with
reversible respiratory and/or cardiac failure. It is utilized in neonates and children who
demonstrate at least an 80 percent predicted mortality secondary to inadequate oxygenation
and ventilation despite maximal conventional management.

[Back to Table of Contents]
What are ECLS support criteria?
The following criteria for ECLS therapy are general guidelines. Patients who do not
fulfill specific criteria are considered on an individual basis.
Neonatal ECLS Support
- Minimum of 33 weeks of completed gestational age
- Reversible pulmonary disease including:
- meconium aspiration
- idiopathic respiratory distress syndrome
- sepsis with pneumonia
- persistent pulmonary hypertension of the newborn
- congenital diaphragmatic hernia
- Predicted mortality of at least 80 percent
[Back to Table of Contents]
Pediatric Respiratory ECLS Support
Criteria defining mortality versus level of respiratory support are not currently
available. Each potential ECLS pediatric respiratory failure patient will be considered on
an individual basis.
Inclusion Criteria
- Severe lung disease with high potential for mortality which has failed to respond to
optimal conventional medical management
- The disease process leading to respiratory failure has potential for reversibility and
recovery
Exclusion Criteria
- Provision of mechanical ventilatory support at levels such that significant (i.e.
irreversible) lung injury is likely to have occurred (i.e. FiO2 >0.6 and/or PEEP >5
for more than 7 continuous days)
- Acutely deteriorating neurologic injury
- Immunodeficiency
- - congenital/acquired associated with limited long-term survival
- - deliberate pharmacologic (i.e. chemotherapy, transplantation)
- Pre-existing severe chronic lung disease
- Congenital anomalies and/or other medical conditions (i.e. irreversible organ failure)
associated with limited long-term survival
[Back to Table of Contents]
Pediatric Cardiac ECLS Support
Criteria defining mortality risks are not currently available. Each potential ECLS
pediatric cardiac failure patient will be considered on an individual basis.
Inclusion Criteria
- Severe cardiovascular failure with high potential for mortality which has failed to
respond to optimal conventional medical management
- The disease process leading to cardiorespiratory failure has potential for reversibility
and recovery
Exclusion Criteria
- Acutely deteriorating neurologic injury (i.e. in neonates > grade I IVH)
- Congenital anomalies and/or medical conditions (i.e. irreversible organ failure,
congenital and/or acquired immunodeficiency) associated with limited long term survival.
.- Presence of a surgically correctable residual cardiac defect.
[Back to Table of Contents]
How do I predict Mortality?
Children's ECLS program uses the Oxygenation Index to predict mortality in neonates. In
older children with respiratory failure, no standardized criteria exist which predict
mortality. Therefore, pediatric patients beyond the neonatal period will be considered on
an individual basis.
The Oxygenation Index is an artificial number calculated as follows:
Oxygenation Index =(mean airway pressure)(fraction of inspired oxygen)(100)
------------------------------------------------------
Postductal PaO2
An Oxygenation Index greater than or equal to 40 in neonates for a minimum of 2 to 4
hours identifies a mortality risk of at least 80 percent. When the predicted mortality is
that elevated, the potential benefits of ECLS likely outweigh the recognized risks, and
cannulation for ECLS is offered.
To calculate oxygenation index
[Back to Table of Contents]
Which infants are NOT candidates for ECLS?
ECLS is not recommended when the child has:
- Major chromosomal anomalies incompatible with reasonable outcome
- Major cardiac or central nervous system malformations
- Intracranial hemorrhage greater than Grade I (subependymal)
- Ventilator support for greater than 10 days
[Back to Table of Contents]
If I suspect a patient may be a candidate for
ECLS, when should I involve the ECLS team?
Call the ECLS team before the Oxygenation Index criteria are met in order to help avoid
the inherent risks of transporting a critically ill and possibly unstable patient. We
suggest that you CONSULT THE ON-CALL ECLS PHYSICIAN WHEN THE OXYGENATION INDEX
REACHES 20. A team member is available 24 hours a day to accept ECLS referrals and
to answer questions.
To calculate oxygenation index
[Back to Table of Contents]
How can I reach the ECLS Team?
The ECLS team can be reached through the Children's Hospital and Regional Medical
Center paging operator at 206-987-2131. Please ask for the ECMO Physician on-call.
Specific questions and comments regarding ECLS therapy should be directed to Dr.
McMullan at 206-987-2762.
Dr. McMullan can also be reached through the Hospital paging
operator at any time, 206-987-2131.
[Back to Table of Contents]
Extracorporeal Life Support Organization
International Summary as of January, 2008
| Group |
Total Reported |
Number Survived to Discharge/Transfer |
Survival |
| Neonatal Respiratory |
21,916 |
16,611 |
76% |
| Neonatal Cardiac |
3,266 |
1,229 |
38% |
| Pediatric Respiratory |
3,693 |
2,057 |
56% |
| Pediatric Cardiac |
4,036 |
1,823 |
45% |
| Adult Respiratory |
1,416 |
721 |
51% |
| Adult Cardiac |
825 |
274 |
33% |
| Total |
36,466 |
23,188 |
64% |
[Back to Table of Contents]
[ELSO Homepage] (Extracorporeal Life
Support Organization, Ann Arbor, MI)
Extracorporeal Life Support Organization
Neonatal Respiratory Case Statistics - International Summary as of January, 2008
| Primary Diagnosis |
Total Runs |
Number Survived |
Survival |
| CDH |
5,411 |
2,780 |
51% |
| MAS |
7,247 |
6,790 |
94% |
| PPHN/PFC |
3,524 |
2,738 |
78% |
| RDS/HMD |
1,447 |
1,218 |
84% |
| Pneumonia/Sepsis |
2,831 |
2,074 |
73% |
| Air Leak Syndrome |
113 |
84 |
74% |
| Other |
1,624 |
1,035 |
64% |
[Back to Table of Contents]
[ELSO Homepage] (Extracorporeal Life
Support Organization, Ann Arbor, MI)
Extracorporeal Life Support Organization
Pediatric Respiratory Case Statistics - International Summary as of January,
2008
| Primary Diagnosis |
Total Runs |
Number Survived |
Survival |
| Bacterial Pneumonia |
412 |
232 |
56% |
| Viral Pneumonia |
868 |
552 |
64% |
| Aspiration |
189 |
125 |
66% |
| Pneumocystis |
26 |
13 |
50% |
| ARDS |
439 |
238 |
54% |
| Respiratory Failure, non-ARDS |
691 |
337 |
49% |
| Other |
1,134 |
589 |
52% |
[Back to Table of Contents]
[ELSO Homepage] (Extracorporeal Life
Support Organization, Ann Arbor, MI)
Extracorporeal Life Support Organization
Cardiac Case Statistics - International Summary as of January, 2008
| Primary Diagnosis |
Total Runs |
Number Survived |
Survival |
| Congenital Defect |
5,780 |
2,252 |
39% |
| Cardiac Arrest |
205 |
63 |
30% |
| Cardiogenic Shock |
229 |
96 |
42% |
| Myocarditis |
255 |
160 |
63% |
| Cardiomyopathy |
611 |
315 |
52% |
| Other |
1,418 |
557 |
39% |
[Back to Table of Contents]
[ELSO Homepage] (Extracorporeal Life
Support Organization, Ann Arbor, MI)
ECLS-NET
The Extracorporeal Life Support Bulletin Board, also called ECLS-NET, is a private, monitored mailing list server.
It is meant as a forum for open discussion of any topic related to Extracorporeal Life Support including (but not limited to):
- Dilemmas in diagnosis and management
- Informal surveys of clinical practice
- Exchange of suggestions regarding patient care
- Development of clinical and laboratory research protocols
- Equipment information exchange
The membership of ECLS-NET can include any health care provider with interest in
Extracorporeal Life Support including physicians, nurses, developmentalists,
perfusionists, or respiratory therapists. ECLS-NET is maintained as a private, automated
mailing list server. Membership is limited to health care professionals and is not open to
the general public. Once you join, you can send messages by electronic mail (E-MAIL) via the Internet to all the subscribers who
can then post replies.
To subscribe, go to ECLS-NET and follow the instructions.
[Back to Table of Contents]
Other ECLS Web Sites on the INTERNET
University of Michigan
Extracorporeal Life Support Home Page
Extracorporeal Life Support Organization Home Page
Great Ormond Street
Hospital ECMO Page
[Back to Table of Contents]
Author
- Dennis Mayock, M.D., Professor, Pediatrics
- Revised and updated for Web Site 1/22/08 by:
|